Cargando…
Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor
Liver cancer is the fastest growing cause of cancer deaths in the United States due to its aggressiveness and lack of effective therapies. The current preclinical study examines valeric acid (pentanoic acid [C(5)H(10)O(2)]), one of the main compounds of valerian root extract, for its therapeutic use...
Autores principales: | Han, Rui, Nusbaum, Olivia, Chen, Xinyi, Zhu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520432/ https://www.ncbi.nlm.nih.gov/pubmed/33024815 http://dx.doi.org/10.1016/j.omto.2020.08.017 |
Ejemplares similares
-
Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer
por: Han, Rui, et al.
Publicado: (2022) -
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
por: Shi, Fengqin, et al.
Publicado: (2021) -
Ultrasound-Assisted Esterification of Valeric Acid to Alkyl Valerates Promoted by Biosilicified Lipases
por: Cebrián-García, Soledad, et al.
Publicado: (2018) -
Tuneable Acidity in Fluorinated Al-SBA-15 Materials for the Esterification of Valeric Acid to Alkyl Valerates
por: Blanco-Sánchez, Miguel, et al.
Publicado: (2020) -
Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways
por: Jayaraj, Richard L., et al.
Publicado: (2020)